DIALYSIS · CCN 112699

USRC CENTRAL VALDOSTA

VALDOSTA, GA 31601

DialysisProfitUS Renal Care, Inc.
$2.7M
TOTAL REVENUE
-6.0%
OPERATING MARGIN
1 / 5
STAR RATING
13
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$2.7M
Total costs
$2.9M
Operating income (rev − costs)
−$164K
Operating margin
-6.0%
Total charges
$2.7M
Total treatments
6,706
Dialysis stations
18

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Percent of Adult HD Patients with Kt/V >= 1.2
DFC_ADULT_HD_KTV
9749—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.8729—
Fistula Rate
DFC_FISTULA_RATE
48.551—
Five Star Rating
DFC_FIVE_STAR
1——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.3327—
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
198.346—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
049—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.83——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2851—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
22.2205—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
4.843—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
28.862—
Standardized ED Visits Ratio
DFC_SEDR
0.7217—